Bio-Techne Corporation
TECH
$48.21
$0.841.77%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 311.42M | 295.88M | 286.56M | 316.96M | 316.18M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 311.42M | 295.88M | 286.56M | 316.96M | 316.18M |
| Cost of Revenue | 101.98M | 102.69M | 96.36M | 105.81M | 101.08M |
| Gross Profit | 209.44M | 193.19M | 190.19M | 211.15M | 215.10M |
| SG&A Expenses | 107.54M | 111.87M | 117.57M | 66.64M | 150.99M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 232.97M | 237.68M | 238.18M | 201.92M | 276.65M |
| Operating Income | 78.45M | 58.20M | 48.38M | 115.05M | 39.54M |
| Income Before Tax | 71.23M | 50.78M | 47.99M | -22.86M | 38.27M |
| Income Tax Expenses | 20.18M | 12.78M | 9.81M | -5.18M | 15.69M |
| Earnings from Continuing Operations | 51.05M | 38.01M | 38.19M | -17.68M | 22.59M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 51.05M | 38.01M | 38.19M | -17.68M | 22.59M |
| EBIT | 78.45M | 58.20M | 48.38M | 115.05M | 39.54M |
| EBITDA | 102.62M | 82.91M | 72.72M | 142.16M | 67.11M |
| EPS Basic | 0.33 | 0.24 | 0.25 | -0.11 | 0.14 |
| Normalized Basic EPS | 0.30 | 0.22 | 0.20 | 0.47 | 0.16 |
| EPS Diluted | 0.32 | 0.24 | 0.24 | -0.12 | 0.14 |
| Normalized Diluted EPS | 0.29 | 0.22 | 0.19 | 0.47 | 0.15 |
| Average Basic Shares Outstanding | 156.33M | 155.84M | 155.46M | 154.91M | 157.37M |
| Average Diluted Shares Outstanding | 157.40M | 157.00M | 156.36M | 155.76M | 158.94M |
| Dividend Per Share | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
| Payout Ratio | 24.52% | 32.81% | 32.59% | -70.07% | 55.69% |